11/3/2026

speaker
Conference Call Operator
Operator

Good afternoon and welcome to Huron Consulting Group's webcast to discuss financial results for the third quarter of 2026. Currently, all conference call lines are in listen-only mode. Later, we will conduct our question and answer session for conference call participants and instructions will follow at that time. As a reminder, this conference call is being recorded. Before we begin, I would like to point all of you to the disclosure at the end of the company's news release for information about any forward-looking statements that may be made or discussed on this call. The news release is posted on Huron's website. Please review that information along with the filings with the SEC for a disclosure of factors that may impact subjects discussed in this afternoon's webcast. The company will be discussing one or more non-GAAP financial measures. Please look at the earnings release and on Huron's website for all of the disclosures required by the SEC, including reconciliation to the most comparable GAAP numbers. And now, I would like to turn the call over to Mark Hussey, Chief Executive Officer and President of Huron Consulting Group. Mr. Hussey, please go ahead.

speaker
Mark Hussey
Chief Executive Officer and President

Good afternoon and welcome to Huron Consulting Group's third quarter 2026 earnings call. With me today are John Kelly, our Chief Financial Officer, and Ronnie Dail, our Chief Operating Officer. We achieved record revenues before reimbursable expenses, or RVR, in the third quarter of 2026, reflecting 12% growth over the third quarter of 2025. Our third quarter performance was driven by organic growth across all three of our operating segments, and double digit percentage growth in both our consulting advantage services and our digital capabilities. AI continues to drive demand for our digital services. In the trailing six months of 2026, greater than 65% of our digital capability bookings involved direct AI scope or delivery that was significantly enabled by our AI tools. And that was up from approximately 50% in the same period in 2025. Our third quarter results continue our strong multi-year performance and further demonstrate the consistent execution by our highly talented global team, as well as the differentiation of our industry-focused proprietary offerings. Combined with our year-to-date performance, our strong backlog and pipeline give us confidence to narrow our four-year RVR guidance range and raise our earnings guidance. At the midpoint, Our updated guidance continues to reflect year-over-year double-digit RBR growth and continued margin expansion, while establishing a solid base for continued growth in 2027. Now I'll share some additional insights into our third quarter performance. In the healthcare segment, we achieved record RBR in the third quarter. RBR grew 16% for the third quarter of 2025, which was on top of 20% growth in Q3 2025 over Q3 of 2024. The increase in RVR in the quarter was driven by strong demand for our managed services, performance improvement, financial advisory, and digital offerings, as well as incremental RVR from our acquisitions. Excluding the impact of the acquisitions, organic RVR growth for the healthcare segment was 9% in Q3 2026 compared to Q3 2025. Underlying market conditions remain favorable for driving strong demand for our healthcare business. Healthcare systems and hospitals continue to operate in a challenging environment characterized by persistent costs and workforce pressures, evolving reimbursement models, and increasing expectations to improve access, outcomes, and the patient experience. The healthcare industry is also preparing for the next phase of the OBDBA, which takes effect in 2027. and include stricter requirements related to Medicaid eligibility and reimbursement. We believe the impending regulatory changes together with the broader structural challenges facing healthcare providers will drive continued demand for our healthcare business. Our comprehensive portfolio of offerings across consulting, digital and managed services positions us well to address each client's distinct challenges. We believe our multi-year track record of proven results coupled with our proprietary data and methodologies and delivered by our highly experienced team provides a strong competitive advantage for Huron as our clients build a more sustainable future for their organizations. I'd also like to highlight the performance of our healthcare managed services business for which RBR nearly doubled the third quarter of 2026 compared to the third quarter of 2025. Q3 2026 marked the third consecutive quarter of 40% plus organic year-over-year revenue growth for this team. The strong, steady growth is reflective of the recurring nature of this offering and our outcomes-based approach that consistently delivers meaningful, positive financial and operational results for our clients. Beyond the impressive growth in financial performance, we're pleased with how this business has organically expanded into a broader scope of functional areas. and hands through our acquisition of RelateCare earlier this year. Our healthcare managed services team has also delivered with the highest quality, achieving a net promoter score of 92, which far exceeds the industry benchmark and states the clear value that we're delivering for our clients. Next, turning to the education segment. In the third quarter of 2026, education RBR grew nearly 7% compared to the third quarter of 2025, driven by strong demand for our digital and managed services offerings. Higher education institutions continue to navigate a broad array of pressures, including demographic headwinds, enrollment challenges, and cost and revenue pressures. Uncertainty also remains around research funding in the midst of growing regulatory complexity. Institutions are also grappling with the risks and opportunities resulting from rapid advances in AI across their workflows and their learning environments. Increasingly, these challenges require institutions to simultaneously rethink their strategies and business models while preserving a clear focus on achieving their missions. We continue to see robust demand for digital transformation engagements as clients seek to modernize their data and technology foundations, build AI-enabled operations, and create a more sustainable operating model. As institutions make increasingly consequential decisions about their future, we believe the depth of our expertise, the breadth of our capabilities, and the deep relationships built over decades provide Huron with a strong competitive advantage. We remain confident in our ability to help clients navigate this period of transformation while continuing to build upon our competitive position in the education market. Now moving to the commercial segment. Third quarter commercial RVR grew 6% over the prior year quarter. The increase in RVR was driven by our Q3 2025 acquisition of Wilson Parable, as well as continued organic growth from our strategy offerings. Commercial organizations are navigating an increasingly complex operating environment marked by cost and productivity pressures, rapid advances in technology and AI, evolving customer expectations, and continued economic and regulatory uncertainty. These challenges are increasingly interconnected, requiring partners that can bring together deep industry expertise across a wide array of capabilities. Similar to our healthcare and education businesses, we believe the growing breadth of our capabilities, along with an increasing depth of industry expertise, positions us well to help clients address these challenges with end-to-end solutions across our commercial segments. Over the past several years, we've strategically strengthened our commercial business by investing in the expansion of our capabilities and industry expertise, and importantly, creating greater connectivity across our businesses. Wilson Parable acquisition completed just over a year ago is a great example. Wilson Parable's expertise in driving performance improvement through managing the strategic and operational impact of complexity on businesses complements our strategy, financial advisory, and digital offerings. Together, we're creating a strategy to execute value proposition to help our clients understand and reduce complexity that erodes value in their businesses. We've seen the benefits of this strategy in the market. Greater collaboration across our teams is expanding how we engage with clients, strengthening our competitive differentiation, and creating new opportunities to serve them across a broader range of needs. We believe this combination of deep industry expertise, broader capabilities, and a collaborative go-to-market approach provides a strong platform for continued growth in our commercial segment. Now let me turn to our outlook for the year. Today we're updating our annual guidance by narrowing our RBR guidance range to a $30 million range of $1.855 billion to $1.885 billion, affirming our adjusted EBITDA guidance range of 14.5% to 15% and increasing and narrowing our adjusted non-GAAP EPS to a range of $9.20 to $9.40. We're pleased with our performance to date in 2026, and the midpoint of our RBR guidance reflects our expectation of continued strong growth in the fourth quarter, consistent with our backlog and pipeline. We remain focused on advancing our growth strategy and executing with discipline to deliver strong financial performance for our business, and for our shareholders. And now let me turn it over to John for a more detailed discussion of our financial results. John?

speaker
John Kelly
Chief Financial Officer

Thank you, Mark, and good afternoon, everyone. Before I begin, please note that I will be discussing non-GAAP financial measures such as EBITDA, adjusted EBITDA, adjusted net income, adjusted EPS, and free cash flow. Our press release, 10Q, and investor relations page on the Huron website have reconciliations of these non-GAAP measures to the most comparable GAAP measures along with the discussion of why management uses these nine gap measures and why management believes they provide useful information to investors regarding our financial condition and operating results. Before discussing our financial results for the quarter, I would like to discuss one housekeeping item. Our healthcare segment results do include a full quarter of operating results from our acquisition of RelayCare, which closed in June of this year. Now I'll share some of the key financial results from the third quarter. The third quarter of 2026 produced record RBR of $482.5 million, up 11.6% from $432.4 million in the same quarter of 2025. The increase in RBR for the quarter was driven by growth across all three operating segments, a double-digit percentage growth in both our consulting and managed services and our digital capabilities. That income for the third quarter of 2026 was $28.4 million, or $1.75 per diluted share, compared to net income of $30.4 million, or $1.71 per diluted share in the third quarter of 2025. As percentage of total revenues, net income decreased to 5.8% in the third quarter of 2026, compared to 6.9% in the third quarter of 2025. Deluded earnings per share in the third quarter of 2026 reflects the non-cash credit loss recognized on our convertible debt investment in the third party, which had a $0.36 unfavorable impact on diluted earnings per share for the quarter. Our effective tax rate in the third quarter of 2026 was 32.9%, which is less favorable than the statutory rate, inclusive of state income taxes, primarily due to certain non-deductible expense items and the inability to recognize tax benefits related to the credit loss recognized on our convertible debt investment in the third party. We now expect a full year effective tax rate between 27 and 29%. Adjusted EBITDA was $77.3 million in Q3, 2026 for 16% of RBR compared to $67.4 million in Q3, 2025 for 15.6% of RBR. The 16% adjusted EBITDA margin is our highest quarterly adjusted EBITDA margin in the last eight years. The increase in adjusted EBITDA was primarily attributable to increases in healthcare and education segment operating income, excluding the impact of segment depreciation and amortization and segment restructuring charges, partially offset by an increase in certain unallocated corporate expenses. The increase in adjusted EBITDA margin to 16% from 15.6% in the prior year period is reflective of an increase in education segment operating income margin, scaling of our unallocated SG&A expenses. Adjusted net income was $42.6 million, or $2.62 per diluted share in Q3, 2026, compared to $37.4 million, or $2.10 per diluted share in third quarter of 2025. growing adjusted diluted earnings per share 24.8% year over year. Now I'll discuss the performance of each of our operating segments. The healthcare segment generated 53% of total company RBR during the third quarter of 2026. Segment posted record RBR of $255.8 million, up $36.2 million, or 16.5% from the third quarter of 2025. driven by strong demand for our managed services, performance improvement, financial advisory, and digital offerings, as well as incremental RBR from our acquisitions. RBR in the third quarter of 2026 included $16.7 million from our acquisitions of RelayCare and Axiom. Operating income margin for the healthcare segment was 30.5% in Q3 2026 compared to 30.9% in Q3 2025. Slight decrease in segment operating income margin is primarily driven by an increase in total compensation expense as a percentage of RBR and includes the impact of the integration of RelayCare into our business. We have maintained strong margin performance in 2025 and into the first nine months of 2026, reflective of the highly disciplined execution delivered by our healthcare team. The education segment generated 29% of total company RBR during the third quarter of 2026. Education segment RBR in the third quarter of 2026 was $138 million, up $8.6 million for 6.6% compared to the third quarter of 2025. The increase in RBR was entirely organic and driven by strong demand for our digital and managed services offering. The operating income margin for education increased to 29.1% for Q3 2026 compared to 25.7% for the third quarter of 2025. The increase was primarily driven by revenue growth that outpaced the increase in salaries and related expenses for our revenue-generating professionals and decreases in salaries and related expenses for our support personnel and technology costs. The commercial segment generated 18% of total company RBR during the third quarter of 2026. Commercial segment RBR was $88.8 million in Q3 2026, up $5.4 million, or 6.4% from the third quarter of 2025. The increase in RBR reflects $4.3 million of incremental RBR, primarily from our acquisition of Wilson Paramel, as well as strong demand for our strategy offering. Operating income margin for the commercial segment was 13.9% for Q3 of 2026, compared to 16.4% in the same quarter in 2025. The decrease was primarily driven by increases in performance bonus expense, reflecting increased full-year performance expectations for certain teams within the segment. In addition to the increase in performance bonus expense, the decline in margin also reflects continued investment in key business development, leadership, and Delivery Talent that we expect to drive above company average growth in 2027. These growth-oriented investments total $2.2 million or 2.5% of segment RBR per quarter. Corporate expenses not allocated at the segment level, excluding restructuring charges, were $58.7 million in Q3 2026 compared to $56.5 million in Q3 2025. Unallocated corporate expenses in the third quarter of 2026 included income of $200,000 compared to expense of $2.7 million in Q3 2025 related to the changes in the liability of our deferred compensation plan, which are offset by the change in fair value of the investment assets used to fund that plan reflected in other income. Excluding the impact of the deferred compensation plan in both periods, Unallocated corporate expenses increased approximately $5.1 million, primarily driven by increases in compensation costs for our support personnel, software and data hosting expenses, partially offset by a decrease in legal expenses. Now turning to the balance sheet and cash flows. DSO came in at 83 days for the third quarter of 2026, compared to 79 days for the second quarter of 2026. The increase when compared to the second quarter of 2026 is primarily attributable to the impact of collections on certain healthcare projects in alignment with the contractual payment schedules. Cash flow from operations in the third quarter of 2026 was $57 million compared to $93.8 million in the prior year period. During the third quarter of 2026, we used $7.9 million to invest in capital expenditures inclusive of internally developed software costs resulting in free cash flow of $49.1 million. We now expect full-year free cash flow to be in a range of $150 million to $170 million net cash taxes and interest excluding non-cash stock compensation. This update primarily reflects the timing of collections, including a revised payment schedule on a specific multi-year engagement and a higher mix of performance improvement projects with performance-based fee elements within our healthcare segment during 2026. We expect to collect working capital related to such projects in 2027 in accordance with our contractual terms. Our leverage ratio is defined in our senior bank agreement was 2.6 times adjusted EBITDA as of September 30th, 2026, compared to 2.8 times as of June 30th, 2026. We remain confident that we are on track to achieving a leverage ratio between 2 and 2.5 times by the end of 2026 in alignment with the capital allocation strategy outlined at our most recent investor day. Total debt as of September 30th, 2026 was $815 million, consisting entirely of our senior bank debt. We finished the quarter with cash of $25.6 million for net debt of $789.4 million. This was a $13.4 billion decrease in net debt compared to Q2 2026, which incorporates the share of repurchases made during the quarter. In the third quarter of 2026, we used $26.3 billion to repurchase approximately 173,000 shares, bringing our total year-to-date repurchases to $234.9 million, or approximately 1.7 million shares. reflecting an average repurchase price of $136 per share. The year-to-date repurchases represent 10% of our common stock outstanding as of December 31st, 2025. As of October 31st, 2026, $265.9 million remained available for share repurchases, inclusive of the $200 million increase authorized by our Board of Directors in October 2026. Finally, let me turn to our guidance for full year 2026. As Mark mentioned, today we are updating our annual guidance by narrowing our RBR guidance to a range of $1.855 billion to $1.885 billion, affirming our adjusted EBITDA guidance range of 14.5% to 15%, and increasing and narrowing our adjusted non-GAAP EPS to a range of $9.20 to $9.40. Thanks, everyone. I would now like to open the call to questions. Operator?

Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Use this data in your own app

Pull this call's transcript, audio and slides with the Earnings call transcripts API.

See pricing

9,000+ companies · REST API